Compound Detail
CHEMBL218974
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL218974 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GPWIINYCHXCGQH-CYBMUJFWSA-N |
5
Targets
6
Activities
1
Assay Types
7
PK Parameters
20
Publications
0
Known Names
Molecular Properties
359.3
MW (Da)
2.92
ALogP
7
HBA
0
HBD
88.7
PSA (Ų)
0.60
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Leishmania donovani CHEMBL367 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
| Leishmania infantum CHEMBL612848 | IC50 | 6.77 | 6.77 | 170.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.58 | 5.58 | 2600.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.98 | 4.98 | 10500.0 | 2 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 4.28 | 4.28 | 53000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1390.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 15800.0 | ng.hr.mL-1 | Mus musculus |
| CL | 11.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 3618.55 | nM | Mus musculus |
| F | 91.0 | % | Mus musculus |
| T1/2 | 2.7 | hr | Mus musculus |
| Tmax | 2.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Leishmania donovani | IC50 | = | 30.0 | nM | 7.52 | Antileishmanial activity against amastigote stage of Leishmania donovani infecte... | 26901446 |
| Leishmania infantum | IC50 | = | 170.0 | nM | 6.77 | Antileishmanial activity against amastigote stage of Leishmania infantum infecte... | 26901446 |
| Trypanosoma cruzi | IC50 | = | 2600.0 | nM | 5.58 | Antitrypanosomal activity against Trypanosoma cruzi infected in human MRC5 cells... | 26901446 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 10500.0 | nM | 4.98 | Inhibition of human ERG expressed in CHOK1 cells by patch clamp method | 28459575 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 10500.0 | nM | 4.98 | Inhibition of human ERG expressed in CHO cells by patch clamp method | 33268145 |
| Trypanosoma brucei | IC50 | = | 53000.0 | nM | 4.28 | Antitrypanosomal activity against trypomastigote stage of Trypanosoma brucei inc... | 26901446 |
Literature References
Data from ChEMBL 36 via Core Engine